Navigation Links
Sinovac Presents at the UBS Global Healthcare Conference in May 2013
Date:5/14/2013

BEIJING, May 14, 2013 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today that management is scheduled to present at the UBS Global Healthcare Conference in New York City. The Sinovac management team inclusive of Nan Wang , Vice President, and Helen Yang , Director, Investor Relations and International Business Development, will present at 10:00 am ET on Monday, May 20, 2013.  

About Sinovac

Sinovac Biotech Ltd. is a China-based biopharmaceutical company that focuses on the research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases including hepatitis A and B, seasonal influenza, H5N1 pandemic influenza (avian flu), H1N1 influenza (swine flu) and mumps, as well as animal rabies vaccine for canines.  The Company recently concluded the phase III clinical trial for enterovirus 71 (against hand, foot and mouth disease).  In 2009, Sinovac was the first company worldwide to receive approval for its H1N1 influenza vaccine, Panflu.1, and has manufactured it for the Chinese Central Government, pursuant to the government-stockpiling program.  The Company is also the only supplier of the H5N1 pandemic influenza vaccine to the government-stockpiling program.  Sinovac is developing a number of new pipeline vaccines including vaccines for pneumococcal polysaccharides, pneumococcal conjugate, varicella and rubella.  Sinovac sells its vaccines mainly in China and exports selected vaccines to Mongolia, Nepal, and the Philippines. Sinovac was also granted a licens
'/>"/>

SOURCE Sinovac Biotech Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Sinovac Files Annual Report on Form 20-F
2. Sinovac EV71 Vaccine Phase III Top-Line Results Presented at 13th Annual World Vaccine Congress & Expo
3. Sinovac Reports Unaudited Third Quarter 2012 Financial Results
4. Sinovac to Host Conference Call to Report Third Quarter 2012 Unaudited Financial Results
5. Sinovac Receives Beijing CDC Tender Award to Supply Seasonal Flu Vaccine Anflu(R) to Beijing Citizens
6. Sinovac Holds 2012 Annual General Meeting of Shareholders
7. Sinovac Reports Unaudited Second Quarter 2012 Financial Results
8. Sinovac to Host Conference Call to Report Second Quarter 2012 Unaudited Financial Results
9. Sinovac Schedules 2012 Annual Meeting of Shareholders
10. Sinovac Reports Progress in EV71 Vaccine Phase III Clinical Trial and Commercialization Preparation Status
11. Sinovac Reports Unaudited First Quarter 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... As health officials across the Midwest warn against the ... Michigan will offer free diagnostic testing ... pharmacists to administer tests and, in some cases, fill the ... in the study. The Grand Rapids, ...
(Date:1/15/2014)... N.J. , Jan. 15, 2014  Celsion Corporation (the "Company") ... has received commitments from institutional investors to purchase an ... stock in an at-the-market registered direct offering, led by ... entered into definitive purchase agreements with these investors pursuant ...
(Date:1/15/2014)... 15, 2014  Humberto C. Antunes,  Galderma  worldwide CEO, will ... Journal of Drugs in Dermatology (JDD) at ... The event is January 17-20, 2014, at the Omni Orlando Resort ... The ODAC is a distinguished event that ...
Breaking Medicine Technology:Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 2Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 3Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4
... BRUNSWICK, N.J., Nov. 28, 2011  Johnson & Johnson (NYSE: ... Annual Health Care Conference on Tuesday, Nov. 29 th at ... Chairman, Ethicon will present in a session scheduled at 8:00 a.m. ... investors and other interested parties by accessing the Johnson & Johnson ...
... 2011 The National Association of Drug Diversion ... cooperation between law enforcement, healthcare professionals, state regulatory ... investigation of drug diversion – today applauded the ... Exchange (NPLEx) demonstrating the real-time, stop-sale system in ...
Cached Medicine Technology:Alabama Stop-Sale System Blocks Illegal Sales & Allows Legal Ones 2
(Date:4/17/2014)... 17, 2014) Two recent papers by a ... colleagues may help scientists develop treatments or vaccines ... Japanese encephalitis and other disease-causing flaviviruses. , Jeffrey ... molecular genetics at the School of Medicine and ... Medical Institute, and colleagues recently published articles in ...
(Date:4/17/2014)... Pediatrician-in-Chief Jon McCullers, MD, was recently invited to ... Nature Reviews Microbiology , one of the ... world-renowned infectious disease specialist, and chair of the ... Health Science Center, analyzed the epidemiology and microbiology ... pandemics, as well as more recent 2009 novel ...
(Date:4/17/2014)... Rochelle, NY, April 17, 2014U.S. military personnel who ... plus impact" concussive traumatic brain injury (TBI) were ... evacuated for other medical reasons. Differences in measures ... depression 6-12 months after injury are reported in ... a peer-reviewed journal from Mary Ann Liebert, Inc., ...
(Date:4/17/2014)... It,s estimated that as many as 10 million older ... of loneliness and isolation. , However, new research ... retired older Americans for six years found that ... of depression by more than 30 percent. , "That,s ... State University professor of telecommunication, information studies and media ...
(Date:4/17/2014)... 17, 2014-- Colic affects about one in five infants ... pediatric visits during the first several months after birth. ... was showing promise; however, the April 1, 2014 issue ... Valerie) reported on a study, "Probiotics and Infant Colic," ... reuteri for infant colic did not reduce ...
Breaking Medicine News(10 mins):Health News:CU researchers discover target for treating dengue fever 2Health News:Long-term effects of battle-related 'blast plus impact' concussive TBI in US military 2Health News:Internet use can help ward off depression among elderly 2Health News:New study says probiotic use for infant colic is not effective in reducing symptoms 2
... NEW YORK, May 16, 2012 -- A collaboration to ... children is being launched by Cincinnati Children,s Hospital Medical ... Negev (BGU) in Beer-Sheva, Israel. The goal is to ... that is customized to meet childrens, unique physiological differences ...
... May 16, 2012The inaugural issue of BioResearch ... access journal, was released today by Mary Ann ... rapid-publication forum for a broad range of scientific ... cellular biology, tissue engineering and biomaterials, regenerative medicine, ...
... Breast cancer stem cells wear a cell surface protein ... as potent tumor-generating cells and flagging their vulnerability to a ... Center report online in Journal of Clinical Investigation . ... stem cells and also found that it,s targetable with a ...
... has replaced another minimally invasive operation as the main ... the diseased organ, and with comparable results, according to ... While the study shows that robot-assisted partial nephrectomy ... complications than laparoscopic partial nephrectomy (LPN), the researchers cautioned ...
... undergo radical surgery for prostate cancer may expect better ... hospitals with residency programs, and better still if the ... study by Henry Ford Hospital. The study, which ... throughout the U.S., also found that those with fewer ...
... Black prostate cancer patients may not be getting ... to a first-of-its-kind study by researchers at Henry Ford ... surgery to remove diseased prostates. While it is ... why the results of radical prostatectomy are not as ...
Cached Medicine News:Health News:Ben-Gurion U. and Cincinnati Children's Hospital to develop pediatric-specific medical technologies 2Health News:Premier issue of BioResearch Open Access launched by Mary Ann Liebert Inc. publishers 2Health News:Scientists discover marker to identify, attack breast cancer stem cells 2Health News:Scientists discover marker to identify, attack breast cancer stem cells 3Health News:Scientists discover marker to identify, attack breast cancer stem cells 4Health News:Robot-assisted surgery now favored treatment for kidney cancer 2Health News:Fewer prostate cancer surgery complications found in teaching hospitals with fellowship programs 2Health News:Quality of care, other issues may cause worse results in black prostate cancer surgery patients 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: